Dr. Martens (LON:DOCS) Insider Buys £149.60 in Stock

Dr. Martens plc (LON:DOCS) insider Giles Wilson purchased 176 shares of Dr. Martens stock in a transaction that occurred on Tuesday, November 11th. The stock was purchased at an average price of GBX 85 per share, with a total value of £149.60.

Giles Wilson also recently made the following trade(s):

• On Monday, October 13th, Giles Wilson acquired 167 shares of Dr. Martens stock. The stock was bought at an average cost of GBX 89 per share, with a total value of £148.63.
• On Wednesday, October 8th, Giles Wilson bought 114 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 90 per share, for a total transaction of £102.60.
• On Thursday, September 11th, Giles Wilson bought 167 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 90 per share, for a total transaction of £150.30.
• On Monday, September 1st, Giles Wilson purchased 105,838 shares of Dr. Martens stock. The stock was bought at an average price of GBX 91 per share, for a total transaction of £96,312.58.
• On Monday, September 1st, Giles Wilson sold 30,000 shares of Dr. Martens stock. The shares were sold at an average price of GBX 91, for a total value of £27,300.
• On Monday, September 1st, Giles Wilson acquired 30,019 shares of Dr. Martens stock. The stock was acquired at an average price of GBX 91 per share, with a total value of £27,317.29.
• On Monday, September 1st, Giles Wilson sold 105,785 shares of Dr. Martens stock. The stock was sold at an average price of GBX 90, for a total value of £95,206.50.

Dr. Martens Stock Performance

LON:DOCS opened at GBX 85.66 on Friday. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. Dr. Martens plc has a fifty-two week low of GBX 43.02 and a fifty-two week high of GBX 100.87. The company has a 50 day simple moving average of GBX 91.07 and a two-hundred day simple moving average of GBX 79.59. The company has a market capitalization of £827.76 million, a PE ratio of 171.32, a P/E/G ratio of 6.40 and a beta of 0.11.

Wall Street Analyst Weigh In

Separately, Peel Hunt raised shares of Dr. Martens to a “buy” rating in a research report on Monday, August 18th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.